Sumitomo Seika Chemicals (4008) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
11 Nov, 2026Executive summary
H1 FY2027 net sales rose 8.0% YoY to ¥78,487 million; operating profit fell 4.9% to ¥5,594 million, while parent-attributable profit increased 13.5% to ¥3,717 million.
Weaker yen and price adjustments supported sales, while lower Super Absorbent Polymers (SAP) profit reflected higher fixed costs from new Singapore capacity and lower volume amid Middle East supply-chain disruption.
Financial highlights
Gross profit was ¥17,052 million versus ¥16,236 million YoY; SG&A rose to ¥11,458 million from ¥10,355 million.
Ordinary profit declined 13.2% to ¥4,842 million; comprehensive income increased to ¥5,083 million from ¥4,272 million.
Total assets rose to ¥159,565 million from ¥152,732 million at FY2026 year-end; net assets increased to ¥106,185 million from ¥103,621 million.
Operating cash flow was an outflow of ¥8,577 million versus an inflow of ¥6,882 million; investing cash outflow was ¥4,634 million and financing cash inflow was ¥7,453 million.
Outlook and guidance
FY2027 forecasts remain unchanged: net sales ¥165,000 million, operating profit ¥11,000 million, ordinary profit ¥11,200 million, and parent-attributable profit ¥8,000 million.
Forecast EPS is ¥124.37; full-year ROE is 7.6% and ROIC 6.1%, versus FY2026 results of 7.8% and 8.1%, respectively.
Forecast assumptions include full-year rates of ¥158.50/$ and ¥23.50/CNY, and naphtha at ¥99,000/KL; Q3-Q4 assumptions are ¥157.50/$ and ¥91,000/KL naphtha.
FY2027 segment forecasts: SAP sales ¥131,200 million and operating profit ¥7,700 million; Functional Materials sales ¥33,500 million and operating profit ¥3,200 million.
Latest events from Sumitomo Seika Chemicals
- SAP expansion and Functional Materials growth anchor the FY2030 plan.4008
Investor presentation - Ambitious 2045 vision and FY2030 targets set, with focus on sustainability and capital efficiency.4008
Investor presentation - Strong sales and profit growth, but FY2027 outlook tempered by rising costs and global risks.4008
Q1 2027 - Profits fell sharply on lower sales and business exits, but full-year profit is forecast to recover.4008
Q1 2025 - Profits surged on strong polymer sales and FX gains, prompting an upward revision to forecasts.4008
Q3 2025 - Operating profit rose despite lower sales, with strong shareholder returns and capacity expansion.4008
Q2 2025 - Sales and operating profit rose, but profit fell on one-time losses; outlook cautious.4008
Q4 2025 - Operating profit up 19.9% despite 1.7% sales drop; profit hit by mischarging provision.4008
Q2 2026 - Profits and shareholder returns rose, but outlook is uncertain due to Middle East risks.4008
Q4 2026